# Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD

> **NCT05879029** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Laryngopharyngeal Reflux

## Interventions

- **DRUG:** Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets.
- **DRUG:** Jinsang Liyan Capsule placebo; Rabeprazole enteric-coated tablets.

## Key facts

- **NCT ID:** NCT05879029
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05879029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05879029, "Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05879029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*